Company overview
Chromacity manufactures ultrafast femtosecond and picosecond lasers optimized for life sciences applications, including fluorescence microscopy, high-resolution imaging, drug discovery, and cancer detection research. Their tunable lasers cover wavelengths from ultraviolet (400 nm) to mid-infrared (>6 µm), supporting gas spectroscopy and real-time identification in solids, liquids, and gases. The company partners with global distributors like Edmund Optics and AMS Technologies for supply across Europe and worldwide.
Chromacity LLC is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include ultrafast lasers, femtosecond lasers, life sciences lasers, pharma imaging, drug discovery lasers.
Structured facts
- Website
- https://chromacity.com/
- Markets served
- United States & Americas
- Keywords
- ultrafast lasers, femtosecond lasers, life sciences lasers, pharma imaging, drug discovery lasers
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
Frequently asked questions
- What laser capabilities does Chromacity offer for pharma R&D?
- Chromacity provides femtosecond and picosecond ultrafast lasers for life science imaging, fluorescence microscopy, drug discovery, and cancer research, with tunable wavelengths from 400 nm UV to >6 µm mid-IR.
- What are Chromacity's global distribution and support options?
- Chromacity partners with Edmund Optics for global distribution, AMS Technologies for Europe, and Tematys for France, offering remote installation and easy-to-use, maintenance-free lasers.
- Are Chromacity lasers suitable for regulatory-compliant pharma environments?
- Chromacity's compact, air-cooled ultrafast lasers feature high stability, single-mode output, and no ongoing maintenance needs, ideal for reliable use in scientific and industrial life sciences settings.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
